Platelet-activating factor podoplanin: from discovery to drug development
Takemoto, Ai, Miyata, Kenichi, Fujita, Naoya
Published in Cancer and metastasis reviews (01.06.2017)
Published in Cancer and metastasis reviews (01.06.2017)
Get full text
Journal Article
Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer
Uchibori, Ken, Inase, Naohiko, Araki, Mitsugu, Kamada, Mayumi, Sato, Shigeo, Okuno, Yasushi, Fujita, Naoya, Katayama, Ryohei
Published in Nature communications (13.03.2017)
Published in Nature communications (13.03.2017)
Get full text
Journal Article
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancer
Gong, Bo, Kiyotani, Kazuma, Sakata, Seiji, Nagano, Seiji, Kumehara, Shun, Baba, Satoko, Besse, Benjamin, Yanagitani, Noriko, Friboulet, Luc, Nishio, Makoto, Takeuchi, Kengo, Kawamoto, Hiroshi, Fujita, Naoya, Katayama, Ryohei
Published in The Journal of experimental medicine (01.04.2019)
Published in The Journal of experimental medicine (01.04.2019)
Get full text
Journal Article
Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer
Mizuta, Hayato, Okada, Koutaroh, Araki, Mitsugu, Adachi, Jun, Takemoto, Ai, Kutkowska, Justyna, Maruyama, Kohei, Yanagitani, Noriko, Oh-Hara, Tomoko, Watanabe, Kana, Tamai, Keiichi, Friboulet, Luc, Katayama, Kazuhiro, Ma, Biao, Sasakura, Yoko, Sagae, Yukari, Kukimoto-Niino, Mutsuko, Shirouzu, Mikako, Takagi, Satoshi, Simizu, Siro, Nishio, Makoto, Okuno, Yasushi, Fujita, Naoya, Katayama, Ryohei
Published in Nature communications (24.02.2021)
Published in Nature communications (24.02.2021)
Get full text
Journal Article
Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis
Takagi, Satoshi, Sasaki, Yuki, Koike, Sumie, Takemoto, Ai, Seto, Yosuke, Haraguchi, Mizuki, Ukaji, Takao, Kawaguchi, Tokuichi, Sugawara, Minoru, Saito, Masanori, Funauchi, Yuki, Ae, Keisuke, Matsumoto, Seiichi, Fujita, Naoya, Katayama, Ryohei
Published in Oncogene (09.09.2021)
Published in Oncogene (09.09.2021)
Get full text
Journal Article
Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms
Yanagitani, Noriko, Uchibori, Ken, Koike, Sumie, Tsukahara, Mika, Kitazono, Satoru, Yoshizawa, Takahiro, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Tambo, Yuichi, Nishikawa, Shingo, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto
Published in Cancer science (01.03.2020)
Published in Cancer science (01.03.2020)
Get full text
Journal Article
Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance
Aoyama, Aki, Katayama, Ryohei, Oh-Hara, Tomoko, Sato, Shigeo, Okuno, Yasushi, Fujita, Naoya
Published in Molecular cancer therapeutics (01.12.2014)
Published in Molecular cancer therapeutics (01.12.2014)
Get full text
Journal Article
Biomarker discovery by integrated joint non-negative matrix factorization and pathway signature analyses
Fujita, Naoya, Mizuarai, Shinji, Murakami, Katsuhiko, Nakai, Kenta
Published in Scientific reports (27.06.2018)
Published in Scientific reports (27.06.2018)
Get full text
Journal Article
Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2
Takagi, Satoshi, Sato, Shigeo, Oh-hara, Tomoko, Takami, Miho, Koike, Sumie, Mishima, Yuji, Hatake, Kiyohiko, Fujita, Naoya
Published in PloS one (21.08.2013)
Published in PloS one (21.08.2013)
Get full text
Journal Article
Herpes Zoster with Contact Dermatitis Developing under a Patch
Kobayashi, Takahiro, Ono, Yosuke, Fujita, Naoya, Tanaka, Yuji
Published in Internal Medicine (01.01.2023)
Published in Internal Medicine (01.01.2023)
Get full text
Journal Article
Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis
Hu, Dong, Gur, Mert, Zhou, Zhuan, Gamper, Armin, Hung, Mien-Chie, Fujita, Naoya, Lan, Li, Bahar, Ivet, Wan, Yong
Published in Nature communications (30.09.2015)
Published in Nature communications (30.09.2015)
Get full text
Journal Article
Cabozantinib overcomes crizotinib resistance in ROS1 fusion-positive cancer
Katayama, Ryohei, Kobayashi, Yuka, Friboulet, Luc, Lockerman, Elizabeth L, Koike, Sumie, Shaw, Alice T, Engelman, Jeffrey A, Fujita, Naoya
Published in Clinical cancer research (01.01.2015)
Published in Clinical cancer research (01.01.2015)
Get full text
Journal Article
The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab
Tanaka, Kazuki, Adams, Brigitte, Aris, Alvaro Madrid, Fujita, Naoya, Ogawa, Masayo, Ortiz, Stephan, Vallee, Marc, Greenbaum, Larry A.
Published in Pediatric nephrology (Berlin, West) (01.04.2021)
Published in Pediatric nephrology (Berlin, West) (01.04.2021)
Get full text
Journal Article
The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models
Katayama, Ryohei, Gong, Bo, Togashi, Noriko, Miyamoto, Masaya, Kiga, Masaki, Iwasaki, Shiho, Kamai, Yasuki, Tominaga, Yuichi, Takeda, Yasuyuki, Kagoshima, Yoshiko, Shimizu, Yuki, Seto, Yosuke, Oh-Hara, Tomoko, Koike, Sumie, Nakao, Naoki, Hanzawa, Hiroyuki, Watanabe, Kengo, Yoda, Satoshi, Yanagitani, Noriko, Hata, Aaron N, Shaw, Alice T, Nishio, Makoto, Fujita, Naoya, Isoyama, Takeshi
Published in Nature communications (09.08.2019)
Published in Nature communications (09.08.2019)
Get full text
Journal Article
APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer
Tanaka, Noritaka, Mashima, Tetsuo, Mizutani, Anna, Sato, Ayana, Aoyama, Aki, Gong, Bo, Yoshida, Haruka, Muramatsu, Yukiko, Nakata, Kento, Matsuura, Masaaki, Katayama, Ryohei, Nagayama, Satoshi, Fujita, Naoya, Sugimoto, Yoshikazu, Seimiya, Hiroyuki
Published in Molecular cancer therapeutics (01.04.2017)
Published in Molecular cancer therapeutics (01.04.2017)
Get full text
Journal Article
Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib
Katayama, Ryohei, Friboulet, Luc, Koike, Sumie, Lockerman, Elizabeth L, Khan, Tahsin M, Gainor, Justin F, Iafrate, A John, Takeuchi, Kengo, Taiji, Makoto, Okuno, Yasushi, Fujita, Naoya, Engelman, Jeffrey A, Shaw, Alice T
Published in Clinical cancer research (15.11.2014)
Published in Clinical cancer research (15.11.2014)
Get full text
Journal Article
Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation
Miyata, Kenichi, Takemoto, Ai, Okumura, Sakae, Nishio, Makoto, Fujita, Naoya
Published in Scientific reports (22.06.2017)
Published in Scientific reports (22.06.2017)
Get full text
Journal Article
The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer
Friboulet, Luc, Li, Nanxin, Katayama, Ryohei, Lee, Christian C, Gainor, Justin F, Crystal, Adam S, Michellys, Pierre-Yves, Awad, Mark M, Yanagitani, Noriko, Kim, Sungjoon, Pferdekamper, AnneMarie C, Li, Jie, Kasibhatla, Shailaja, Sun, Frank, Sun, Xiuying, Hua, Su, McNamara, Peter, Mahmood, Sidra, Lockerman, Elizabeth L, Fujita, Naoya, Nishio, Makoto, Harris, Jennifer L, Shaw, Alice T, Engelman, Jeffrey A
Published in Cancer discovery (01.06.2014)
Published in Cancer discovery (01.06.2014)
Get full text
Journal Article